Brazil Asthma Therapeutics Market Size & Outlook
Brazil asthma therapeutics market, 2018-2030 (US$M)
Related Markets
Brazil asthma therapeutics market highlights
- The Brazil asthma therapeutics market generated a revenue of USD 457.2 million in 2023 and is expected to reach USD 728.8 million by 2030.
- The Brazil market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
- In terms of segment, anti- inflammatories was the largest revenue generating drug class in 2023.
- Combination therapy is the most lucrative drug class segment registering the fastest growth during the forecast period.
Asthma therapeutics market data book summary
| Market revenue in 2023 | USD 457.2 million |
| Market revenue in 2030 | USD 728.8 million |
| Growth rate | 6.9% (CAGR from 2023 to 2030) |
| Largest segment | Anti- inflammatories |
| Fastest growing segment | Combination therapy |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anti- inflammatories, Bronchodilators, Combination therapy |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, GSK PLC, Merck & Co Inc, Roche Holding AG, AstraZeneca PLC, Boehringer Ingelheim, Sanofi SA, Koninklijke Philips NV, BD, Corvus Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.7% of the global asthma therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil asthma therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 728.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Asthma Therapeutics Market Scope
Asthma Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil asthma therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to asthma therapeutics market will help companies and investors design strategic landscapes.
Anti- inflammatories was the largest segment with a revenue share of 61.7% in 2023. Horizon Databook has segmented the Brazil asthma therapeutics market based on anti- inflammatories, bronchodilators, combination therapy covering the revenue growth of each sub-segment from 2018 to 2030.
In LATAM, Brazil has the largest population. Brazil has been experiencing positive economic growth due to recent financial and political stability. Healthcare expenditure in Brazil is around USD 190 billion, which is among the highest in the world.
Its biopharmaceutical industry is witnessing significant growth due to the increasing government investments to improve healthcare. Lung diseases are a major cause of death in Brazil. According to an NCBI report published in 2019, the estimated asthma patient population in Brazil is around 20 million, characterized by elevated morbidity and notable mortality rates.
The overall prevalence of asthma in the country is estimated to be approximately 9%. In the adult demographic, the prevalence of physician-diagnosed asthma is estimated to be 4.4%.
Reasons to subscribe to Brazil asthma therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil asthma therapeutics market databook
-
Our clientele includes a mix of asthma therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil asthma therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil asthma therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil asthma therapeutics market size, by drug class, 2018-2030 (US$M)
Brazil Asthma Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
